BIO.News Newsletter

BIO experts have been analyzing the 4,155-page omnibus spending bill since it was delivered around 2 a.m. yesterday. There are key provisions related to biopharma, agriculture, and environment. (805 words, 4 minutes, 1 second)

We’re officially in the home stretch of the year. Today, we have news on Mexico’s proposed corn ban, a recap of BIO’s event during the U.S.-Africa Summit and what it means for cancer in Africa, and a lot more health news. (791 words, 3 minutes, 57 seconds)

For your weekend reading, we have our 2022 midterms recap: what happened, why it matters, and what the results mean for biotech innovation and patients. Plus, ahead of Agriculture Secretary Vilsack’s meeting with Mexico today, bipartisan Senators are calling for the U.S. to take action on the proposed corn ban. (740 words, 3 minutes, 42 seconds)

With appropriations negotiations underway on Capitol Hill, we look at what some members of Congress want the package to say about genome editing for food. Plus,the FDA cut back on use of Accelerated Approval in 2022—a very unwelcome holiday surprise for patients.  (634 words, 3 minutes, 10 seconds)

Hard to believe the first COVID vaccines were administered in the U.S. two years ago today—here’s more on the impact on lives and money saved, and future R&D. Plus, President Biden’s hosting the U.S.-Africa Leaders Summit and today will highlight the role for biotech. (501 words, 2 minutes, 30 seconds)

Recent data provides more evidence of the need for equity and inclusion in clinical trials and drug development—here’s what we’re doing about it. And while we know the lame duck is busy, the Senate should add two key agriculture nominations to the agenda. (551 words, 2 minutes, 45 seconds)

A new WHO report highlights how common bacteria are growing more resistant to antibiotics—but you can take action this week. Plus, bipartisan House Ways & Means Committee members are calling for USTR to open a dispute settlement with Mexico. (650 words, 3 minutes, 15 seconds)

We’re ending the week with a focus on vaccines: the importance of getting the flu vaccine, a promising new dengue vaccine, and an exclusive must-read on how Dobbs v. Jackson could impact future vaccine R&D. (523 words, 2 minutes, 36 seconds)

A lot of news about biotech breakthroughs, from progress on cancer treatments to a new dengue vaccine. Plus, we look at the impact of COVID-19 on supply chains, and why we have a chance to reimagine them. (657 words, 3 minutes, 17 seconds)

USTR wants to extend the deadline to decide on the expansion of the COVID IP waiver—a good sign, we hope. Plus, the COP15 biodiversity conference begins, and two important health awareness weeks come to an end. (862 words, 4 minutes, 18 seconds)